Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1Wavelength Enterprises LTD
02 2USV Private Limited
03 1AX Pharmaceutical Corp
04 1Arch Pharmalabs Limited
05 1DARMERICA, LLC
06 1Fagron Inc
07 1Glenmark Life Sciences Limited
08 1Professional Compounding Centers of America
09 1SOLARA ACTIVE PHARMA SCIENCES LIMITED
10 1TAPI Hungary Industries Kft.
11 1Wanbury Limited
01 1IMIQUIMOD
02 10Imiquimod
03 1imiquimod
01 1Canada
02 1France
03 6India
04 1Netherlands
05 1U.S.A
06 1United Kingdom
07 1Blank
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0397
Start Marketing Date : 2004-09-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0072
Start Marketing Date : 2009-12-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0087
Start Marketing Date : 2009-11-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22365-121
Start Marketing Date : 2005-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-160
Start Marketing Date : 2019-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25g/25g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1538
Start Marketing Date : 2018-01-03
End Marketing Date : 2027-05-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66039-829
Start Marketing Date : 2006-09-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0168
Start Marketing Date : 2020-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 72643-006
Start Marketing Date : 2011-01-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62350-0077
Start Marketing Date : 2017-01-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Imiquimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imiquimod, including repackagers and relabelers. The FDA regulates Imiquimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imiquimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imiquimod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imiquimod supplier is an individual or a company that provides Imiquimod active pharmaceutical ingredient (API) or Imiquimod finished formulations upon request. The Imiquimod suppliers may include Imiquimod API manufacturers, exporters, distributors and traders.
click here to find a list of Imiquimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imiquimod as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imiquimod API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imiquimod as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imiquimod and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imiquimod NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imiquimod suppliers with NDC on PharmaCompass.
We have 10 companies offering Imiquimod
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
